Inoviem has been selected together with 25 European companies to join a mission organized by the European commission to attend the BioJapan 2019 conference
Inoviem has been selected together with 25 European companies to join a mission organized by the EU-Japan center for industrial cooperation to attend the BioJapan conference in Yokohama from October the 8th to the 11th. This mission is financially supported by the European Union to enhance cooperations between Japanese and European companies. You can meet Dr Pierre Eftekhari, Inoviem’s President, and Dr Daniel Da Costa, Inoviem’s Head of Business Development. Inoviem will present its unique approach to bridge the clinic and the preclinic and secure the development of therapeutic agents, with its cutting-edge label-free technologies NPOT® and PIMS®, during a speech at BioJapan. Come on booth B-16 and meet us for a discussion on how Inoviem’s approach will provide you with value in your drug discovery and development process. We are looking forward to meeting you in Yokohama.